The Coalition’s role is first, to defend the rights of medical professionals and consumers to receive appropriate healthcare information, and second, to act to prevent or reverse actions interfering with the free flow of healthcare information.

Whenever open communication regarding a pharmaceutical or medical product is obstructed, the Coalition proactively explores ways to break down barriers. Issues are raised and discussed in depth at regular executive monthly committee meetings, typically held in New York City. Subcommittees are often formed to research specific topics and propose solutions to the larger group.

Once the Coalition thoroughly investigates an issue, it formulates a position that reflects the concerns and desires of its member organizations. Often, it seeks input from other important authoritative bodies.